STOCK TITAN

DocuSign (DOCU) director exercises 725 RSUs, sells 363 shares under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

DocuSign director Anna Marrs reported an option exercise and a small share sale. On June 4, 2026, she exercised 725 restricted stock units, converting them into 725 shares of common stock at an exercise price of $0.00 per share. On June 5, 2026, she then executed an open-market sale of 363 common shares at $49.42 per share under a pre-arranged Rule 10b5-1 trading plan, leaving her with 12,977 common shares held directly after the transactions.

Positive

  • None.

Negative

  • None.
Insider Marrs Anna
Role null
Sold 363 shs ($18K)
Type Security Shares Price Value
Sale Common Stock 363 $49.42 $18K
Exercise Restricted Stock Units 725 $0.00 --
Exercise Common Stock 725 $0.00 --
Holdings After Transaction: Common Stock — 12,977 shares (Direct, null); Restricted Stock Units — 0 shares (Direct, null)
Footnotes (1)
  1. The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in twelve equal quarterly installments over three years, with a vesting commencement date of June 4, 2023, in each case subject to the Reporting Person being a service provider through each such date. The RSUs do not expire; they either vest or are canceled prior to vesting date.
Shares sold 363 shares Open-market sale on June 5, 2026
Sale price per share $49.42 per share Open-market sale of common stock
Shares acquired via RSU exercise 725 shares RSU conversion on June 4, 2026
RSU exercise price $0.00 per share Conversion of restricted stock units
Shares held after transactions 12,977 shares Direct ownership after June 5, 2026
Rule 10b5-1 plan regulatory
"The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
restricted stock unit ("RSU") financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock."
vesting commencement date financial
"The RSUs will vest in twelve equal quarterly installments over three years, with a vesting commencement date of June 4, 2023,"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
contingent right financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Marrs Anna

(Last)(First)(Middle)
C/O DOCUSIGN, INC.
221 MAIN STREET, SUITE 800

(Street)
SAN FRANCISCO CALIFORNIA 94105

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
DOCUSIGN, INC. [ DOCU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/04/2026M725A$013,340D
Common Stock06/05/2026S363(1)D$49.4212,977D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(2)06/04/2026M725 (3) (4)Common Stock725$00D
Explanation of Responses:
1. The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
3. The RSUs will vest in twelve equal quarterly installments over three years, with a vesting commencement date of June 4, 2023, in each case subject to the Reporting Person being a service provider through each such date.
4. The RSUs do not expire; they either vest or are canceled prior to vesting date.
Remarks:
/s/ Derrick Chapman, Attorney-in-fact06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did DOCUSIGN (DOCU) director Anna Marrs report?

Anna Marrs reported exercising 725 restricted stock units into common stock and selling 363 DOCUSIGN shares. The sale occurred at $49.42 per share, and she held 12,977 shares directly after these transactions.

How many DOCUSIGN (DOCU) shares did Anna Marrs sell and at what price?

She sold 363 DOCUSIGN common shares in an open-market transaction at $49.42 per share. This transaction was reported as a routine Form 4 insider sale and was executed under a pre-arranged Rule 10b5-1 trading plan.

Did Anna Marrs acquire additional DOCUSIGN (DOCU) shares in this Form 4?

Yes. She acquired 725 DOCUSIGN common shares by exercising 725 restricted stock units at an exercise price of $0.00. Each restricted stock unit converted into one share of common stock according to the terms described in the filing footnotes.

How many DOCUSIGN (DOCU) shares does Anna Marrs hold after these transactions?

After the reported transactions, Anna Marrs directly holds 12,977 DOCUSIGN common shares. This figure reflects her position following the 725-share RSU conversion and the 363-share open-market sale disclosed in the Form 4.

Was the DOCUSIGN (DOCU) insider sale by Anna Marrs under a Rule 10b5-1 plan?

Yes. The filing states that the sale transaction was effected pursuant to a Rule 10b5-1 trading plan. Such plans allow insiders to pre-schedule trades, making the timing of sales less indicative of their current views on the stock.